MTOR and ovarian carcinoma: Additionally, miR-718 represses VEGF and inhibits ovarian cancer cell progression, and mediates Nef- and K1-induced angiogenesis via activation of AKT/mTOR signaling in AIDS-Kaposi's sarcoma [15, 16].